Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Terry

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Journal of Neurointerventional Surgery|May 15, 2012
Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomesRishi Gupta, Anat Horev, Thanh Nguyen, et al.
Cancer Letters|February 17, 2019
Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cellsYongmei Feng, E Hampton Sessions, Fan Zhang, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 20, 2014
Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic strokeShyam Prabhakaran, Tudor G Jovin, Ashis H Tayal, et al.
American Journal of Human Genetics|April 3, 2012
Rare mutations in XRCC2 increase the risk of breast cancerD J Park, F Lesueur, T Nguyen-Dumont, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Human Molecular Genetics|May 20, 2011
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Journal of Neurointerventional Surgery|May 15, 2012
Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomesRishi Gupta, Anat Horev, Thanh Nguyen, et al.
Cancer Letters|February 17, 2019
Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cellsYongmei Feng, E Hampton Sessions, Fan Zhang, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 20, 2014
Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic strokeShyam Prabhakaran, Tudor G Jovin, Ashis H Tayal, et al.
American Journal of Human Genetics|April 3, 2012
Rare mutations in XRCC2 increase the risk of breast cancerD J Park, F Lesueur, T Nguyen-Dumont, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Human Molecular Genetics|May 20, 2011
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, et al.
Pageof 27